---
title: "Clearside Biomedical Faces Nasdaq Delisting After Bankruptcy Filing"
description: "Clearside Biomedical Inc. faces Nasdaq delisting after filing for Chapter 11 bankruptcy. Trading was suspended on December 1, 2025, and the company filed a Form 25 with the SEC to deregister its share"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/268997434.md"
published_at: "2025-12-08T21:33:26.000Z"
---

# Clearside Biomedical Faces Nasdaq Delisting After Bankruptcy Filing

> Clearside Biomedical Inc. faces Nasdaq delisting after filing for Chapter 11 bankruptcy. Trading was suspended on December 1, 2025, and the company filed a Form 25 with the SEC to deregister its shares. The stock now trades on the OTC Pink Limited Market, reducing SEC reporting obligations. This news was generated by Public Technologies using AI and is not financial advice.

Clearside Biomedical Inc. is facing a significant regulatory issue following its voluntary Chapter 11 bankruptcy filing. As a result, the company received notice from Nasdaq that its common stock would be delisted, and trading was suspended as of December 1, 2025. Clearside subsequently filed a Form 25 with the SEC to officially remove its shares from Nasdaq and deregister them under Section 12(b) of the Securities Exchange Act of 1934. This move will reduce certain SEC reporting obligations for the company. The stock now trades on the OTC Pink Limited Market. No tariff-related issues were mentioned. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearside Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-311305), on December 08, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CLSDQ.US - CLEARSIDE BIOMEDICAL INC](https://longbridge.com/en/quote/CLSDQ.US.md)
- [CLSD.US - Clearside Biomedical](https://longbridge.com/en/quote/CLSD.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 最高法院推翻了特朗普的關税政策。接下來是艱難的退款工作 | 最高法院已宣佈特朗普總統的主要關税無效，這引發了對已經徵收的 1330 億美元非法進口税的質疑。公司正在尋求退款，但處理這些退款的流程仍不確定 | [Link](https://longbridge.com/en/news/276504104.md) |
| 聊天機器人能否為香港人算命，還是隻是憑空編造？ | 香港風水大師警告不要依賴人工智能聊天機器人進行算命，稱其可能產生不準確的預測。儘管一些用户聲稱結果驚人地準確，但專家警告説，人工智能缺乏進行形而上學洞察所需的深度理解。對像 Gemini 和 DeepSeek 這樣的聊天機器人的測試顯示，預 | [Link](https://longbridge.com/en/news/276106516.md) |
| 用 AI 模擬新加坡教師 隨時隨地幫學生加強數學能力 \| 聯合早報網 | WizzTutor 聯合創辦人徐錦泉和張健倫利用人工智能技術創建了一個在線教育平台，旨在幫助學生隨時隨地提高數學能力。徐錦泉的創意源於他作為教師時發現學生深夜仍在學習的現象。WizzTutor 提供便捷的在線服務，學生只需使用 iPad 或 | [Link](https://longbridge.com/en/news/276220565.md) |
| 年輕移民在推動生物醫學科學方面取得進展，有資格獲得 5 萬美元的 Vilcek 創意承諾獎 | 維爾切克基金會正在接受 2027 年維爾切克生物醫學科學創意承諾獎的申請，截止日期為 2026 年 5 月 4 日。這些 5 萬美元的獎項旨在表彰在美國的三位年輕移民科學家，他們在各個生物醫學領域表現出色。符合條件的申請者必須年齡在 38  | [Link](https://longbridge.com/en/news/276151122.md) |
| 報道：AI 軍事用途存分歧，美國國防部接近與 Anthropic 切斷關係 | 報道稱，雙方關係破裂源於數月來圍繞美國軍方如何使用 Claude 工具的激烈談判。Anthropic 特別希望確保其人工智能不會被用於大規模監控公民，或用於開發無需人類參與即可部署的武器。美國政府方面則希望能夠將 Claude 用於 “所有 | [Link](https://longbridge.com/en/news/276069534.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.